Compare J B Hunt Transport Services Inc (JBHT) vs Medpace Holdings Inc (MEDP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
J B Hunt Transport Services Inc vs Medpace Holdings Inc — how do they compare? J B Hunt Transport Services Inc trades at $229.59 (market cap $21.45B), while Medpace Holdings Inc trades at $611.57 (market cap $16.82B). The key difference: J B Hunt Transport Services Inc is the larger of the two by market cap, and J B Hunt Transport Services Inc pays a 0.79% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold J B Hunt Transport Services Inc for 46 Days and Medpace Holdings Inc for 14 Days on average.
| JBHT | MEDP | |
|---|---|---|
Market Cap | $21.45B | $16.82B |
Volume | 1,028,680 | 223,093 |
Sector | Industrials | Health |
52-Week High | $298.41 | $630.19 |
52-Week Low | $137.09 | $393.42 |
Typical Hold Time | 46 Days | 14 Days |
Enterprise Value | $22.59B | $16.44B |
Dividend Yield | 0.79% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
JBHT trades at $229.26, up 2.97% today, amid a bearish technical signal but strong analyst support. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results pending. Revenue has stabilized around $12B, while profitability metrics like ROE (18.45%) and net margin (5.31%) remain solid. However, rising costs and ongoing securities litigation investigations present headwinds.
The outlook is mixed: Wall Street's consensus price target of $289.40 implies significant upside, but near-term pressure from fuel costs and legal overhangs may limit gains. Investors should weigh strong fundamentals against operational risks and market sentiment shifts ahead of Q3 earnings.
MEDP trades at $612.05, up 1.29% today, near its consensus price target of $620.44. The stock shows strong profitability with a 17.67% net margin and has beaten earnings estimates for the last three quarters. Technical indicators are neutral overall, with support at $595 and resistance at $612. Recent news highlights CEO stock sales and institutional position changes, while the company prepares to report Q3 2026 results on October 21.
Outlook remains positive given consistent earnings beats and projected revenue growth to $2.8B in 2026. Risks include high valuation multiples (P/E 35.41) and insider selling. Analyst consensus is cautious with 79% hold ratings, suggesting limited near-term upside but solid fundamental support for long-term holders.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About J B Hunt Transport Services Inc
J.B. Hunt Transport Services ranks among the top surface transportation companies in North America by revenue. Its primary operating segments are intermodal delivery, which uses the Class I rail carriers for the underlying line-haul movement of its owned containers (45% of sales in 2021).
Read more on JBHT →About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →
